Your browser doesn't support javascript.
loading
Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis.
Weinstock, Ada; Rahman, Karishma; Yaacov, Or; Nishi, Hitoo; Menon, Prashanthi; Nikain, Cyrus A; Garabedian, Michela L; Pena, Stephanie; Akbar, Naveed; Sansbury, Brian E; Heffron, Sean P; Liu, Jianhua; Marecki, Gregory; Fernandez, Dawn; Brown, Emily J; Ruggles, Kelly V; Ramsey, Stephen A; Giannarelli, Chiara; Spite, Matthew; Choudhury, Robin P; Loke, P'ng; Fisher, Edward A.
Afiliación
  • Weinstock A; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Rahman K; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Yaacov O; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Nishi H; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Menon P; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Nikain CA; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Garabedian ML; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Pena S; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Akbar N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Sansbury BE; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States.
  • Heffron SP; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Liu J; NYU Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine, New York, United States.
  • Marecki G; Department of Surgery, Mount Sinai School of Medicine, New York, United States.
  • Fernandez D; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Brown EJ; Cardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Ruggles KV; Department of Medicine, Leon H. Charney Division of Cardiology, Cardiovascular Research Program, New York University Grossman School of Medicine, New York, United States.
  • Ramsey SA; Division of Translational Medicine, Department of Medicine, New York University Langone Health, Institute for Systems Genetics, New York University Grossman School of Medicine, New York, United States.
  • Giannarelli C; Department of Biomedical Sciences, School of Electrical Engineering and Computer Science, Oregon State University, Corvallis, United States.
  • Spite M; Cardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Choudhury RP; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Loke P; Department of Microbiology (Parasitology), New York University School of Medicine, New York, United States.
  • Fisher EA; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States.
Elife ; 102021 03 15.
Article en En | MEDLINE | ID: mdl-33720008
ABSTRACT
Atherosclerosis is a disease of chronic inflammation. We investigated the roles of the cytokines IL-4 and IL-13, the classical activators of STAT6, in the resolution of atherosclerosis inflammation. Using Il4-/-Il13-/- mice, resolution was impaired, and in control mice, in both progressing and resolving plaques, levels of IL-4 were stably low and IL-13 was undetectable. This suggested that IL-4 is required for atherosclerosis resolution, but collaborates with other factors. We had observed increased Wnt signaling in macrophages in resolving plaques, and human genetic data from others showed that a loss-of-function Wnt mutation was associated with premature atherosclerosis. We now find an inverse association between activation of Wnt signaling and disease severity in mice and humans. Wnt enhanced the expression of inflammation resolving factors after treatment with plaque-relevant low concentrations of IL-4. Mechanistically, activation of the Wnt pathway following lipid lowering potentiates IL-4 responsiveness in macrophages via a PGE2/STAT3 axis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-4 / Aterosclerosis / Vía de Señalización Wnt / Macrófagos Límite: Animals / Female / Humans / Male Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-4 / Aterosclerosis / Vía de Señalización Wnt / Macrófagos Límite: Animals / Female / Humans / Male Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos